Advertisement
Abbott recall signals new era in medical-device cybersecurity

Abbott recall signals new era in medical-device cybersecurity

By Rachel Z. Arndt  |  September 01, 2017

The FDA's recall of 465,000 Abbott Laboratories pacemakers earlier this week alerted medical-device makers that they increasingly need to be prepared to issue security updates and take cybersecurity issues more seriously.

St. Jude Medical concealed defects in devices, FDA says

St. Jude Medical concealed defects in devices, FDA says

By Maria Castellucci  |  April 14, 2017

St. Jude Medical, which is now part of Abbott Laboratories, failed to appropriately correct issues found in some of its cardiovascular devices, according to the U.S. Food and Drug Administration.

Commentary: Hospitals need better cybersecurity, not more fear

By Kevin Fu, Dr. John Halamka, Jack Kufahl and Mary Logan  |  September 14, 2016

The recent fracas over the Muddy Waters report about St. Jude Medical's devices raises a number of questions, such as: What are appropriate ways to disclose a vulnerability that may have clinical implications?

Researchers question report alleging vulnerabilities in St. Jude devices

By Maria Castellucci  |  August 31, 2016

Medical-device manufacturer St. Jude Medical once again denied allegations Tuesday that its pacemakers and other devices had security weaknesses, while independent researchers found flaws in a critical report by the short-selling investment firm Muddy Waters and cybersecurity company MedSec.

Community Health Systems spins off Quorum unit

By Modern Healthcare  |  April 30, 2016

Community Health Systems has completed its spinoff of 38 hospitals into a separate, independent company, Quorum Health Corp. Quorum begins trading to the general public on Monday under the symbol QHC.

Abbott to spend $19.3B to buy St. Jude Medical

By Associated Press  |  April 28, 2016

Abbott Laboratories will spend $19.3 billion to buy St. Jude Medical in a cash-stock deal that aims to strengthen the medical-device maker's share of the market for cardiovascular care.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print